MRKR – Marker Therapeutics Inc
MRKR — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
1.12
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
0.04
EPS Last/This Y
0.24
EPS This/Next Y
0.38
Price
1.42
Target Price
7.87
Analyst Recom
1
Performance Q
-4.76
Upside
-722.1%
Beta
1.43
Ticker: MRKR
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-04-23 | MRKR | 1.45 | N/A | N/A | 0 |
| 2026-04-24 | MRKR | 1.425 | N/A | N/A | 0 |
| 2026-04-27 | MRKR | 1.455 | N/A | N/A | 0 |
| 2026-04-28 | MRKR | 1.43 | N/A | N/A | 0 |
| 2026-04-29 | MRKR | 1.45 | N/A | N/A | 0 |
| 2026-04-30 | MRKR | 1.48 | N/A | N/A | 0 |
| 2026-05-01 | MRKR | 1.47 | N/A | N/A | 0 |
| 2026-05-04 | MRKR | 1.5501 | N/A | N/A | 0 |
| 2026-05-05 | MRKR | 1.51 | N/A | N/A | 0 |
| 2026-05-06 | MRKR | 1.47 | N/A | N/A | 0 |
| 2026-05-07 | MRKR | 1.45 | N/A | N/A | 0 |
| 2026-05-08 | MRKR | 1.46 | N/A | N/A | 0 |
| 2026-05-11 | MRKR | 1.45 | N/A | N/A | 0 |
| 2026-05-12 | MRKR | 1.45 | N/A | N/A | 0 |
| 2026-05-13 | MRKR | 1.45 | N/A | N/A | 0 |
| 2026-05-14 | MRKR | 1.47 | N/A | N/A | 0 |
| 2026-05-15 | MRKR | 1.43 | N/A | N/A | 0 |
| 2026-05-18 | MRKR | 1.4006 | N/A | N/A | 0 |
| 2026-05-19 | MRKR | 1.405 | N/A | N/A | 0 |
| 2026-05-20 | MRKR | 1.41 | N/A | N/A | 0 |
| 2026-05-21 | MRKR | 1.44 | N/A | N/A | 0 |
| 2026-05-22 | MRKR | 1.41 | N/A | N/A | 0 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-04-23 | MRKR | 1.45 | - | - | -0.61 |
| 2026-04-24 | MRKR | 1.41 | - | - | -0.61 |
| 2026-04-27 | MRKR | 1.49 | - | - | -0.61 |
| 2026-04-28 | MRKR | 1.42 | - | - | -0.61 |
| 2026-04-30 | MRKR | 1.48 | - | - | -0.61 |
| 2026-05-01 | MRKR | 1.47 | - | - | -0.61 |
| 2026-05-04 | MRKR | 1.59 | - | - | -0.61 |
| 2026-05-05 | MRKR | 1.50 | - | - | -0.61 |
| 2026-05-06 | MRKR | 1.46 | - | - | -0.61 |
| 2026-05-07 | MRKR | 1.45 | - | - | -0.61 |
| 2026-05-08 | MRKR | 1.46 | - | - | -0.61 |
| 2026-05-11 | MRKR | 1.47 | - | - | -0.61 |
| 2026-05-12 | MRKR | 1.45 | - | - | -0.61 |
| 2026-05-13 | MRKR | 1.45 | - | - | -0.61 |
| 2026-05-14 | MRKR | 1.46 | - | - | -0.61 |
| 2026-05-15 | MRKR | 1.44 | - | - | -0.61 |
| 2026-05-18 | MRKR | 1.40 | - | - | -0.61 |
| 2026-05-19 | MRKR | 1.41 | - | - | -0.61 |
| 2026-05-20 | MRKR | 1.42 | - | - | -0.61 |
| 2026-05-21 | MRKR | 1.43 | - | - | -0.61 |
| 2026-05-22 | MRKR | 1.42 | 44.8 | - | -0.55 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-04-23 | MRKR | 0.00 | 4.57 | 3.78 |
| 2026-04-24 | MRKR | 0.00 | 4.57 | 3.78 |
| 2026-04-27 | MRKR | 0.00 | 4.57 | 1.41 |
| 2026-04-28 | MRKR | 0.00 | 4.57 | 1.41 |
| 2026-04-29 | MRKR | 0.00 | 4.57 | 1.41 |
| 2026-04-30 | MRKR | 0.00 | 4.57 | 1.41 |
| 2026-05-01 | MRKR | 0.00 | 4.57 | 1.41 |
| 2026-05-04 | MRKR | 0.00 | 4.57 | 1.41 |
| 2026-05-05 | MRKR | 0.00 | 4.57 | 1.41 |
| 2026-05-06 | MRKR | 0.00 | 4.57 | 1.41 |
| 2026-05-07 | MRKR | 0.00 | 4.57 | 1.41 |
| 2026-05-08 | MRKR | 0.00 | 4.57 | 1.41 |
| 2026-05-11 | MRKR | 0.00 | 4.45 | 1.41 |
| 2026-05-12 | MRKR | 0.00 | 4.45 | 1.12 |
| 2026-05-13 | MRKR | 0.00 | 4.45 | 1.12 |
| 2026-05-14 | MRKR | 0.00 | 4.45 | 1.12 |
| 2026-05-15 | MRKR | 0.00 | 4.45 | 1.12 |
| 2026-05-18 | MRKR | 0.00 | 4.60 | 1.12 |
| 2026-05-19 | MRKR | 0.00 | 4.60 | 1.12 |
| 2026-05-20 | MRKR | 0.00 | 4.60 | 1.12 |
| 2026-05-21 | MRKR | 0.00 | 4.60 | 1.12 |
| 2026-05-22 | MRKR | 0.00 | 4.60 | 1.12 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.16
Avg. EPS Est. Current Quarter
-0.16
Avg. EPS Est. Next Quarter
-0.12
Insider Transactions
Institutional Transactions
4.6
Beta
1.43
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
7
Growth Score
23
Sentiment Score
45
Actual DrawDown %
96.1
Max Drawdown 5-Year %
-98
Target Price
7.87
P/E
Forward P/E
PEG
P/S
7.29
P/B
1.69
P/Free Cash Flow
EPS
-0.67
Average EPS Est. Cur. Y
-0.55
EPS Next Y. (Est.)
-0.17
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-340.78
Relative Volume
0.55
Return on Equity vs Sector %
-106
Return on Equity vs Industry %
-90.4
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.06
EBIT Estimation
◆
MRKR
Healthcare
$1.40
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
44.1
Range 1M
25%
Sup Dist
0.5%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-21.9%
EPS NY
-5.2%
52W%
18.7%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+462.1% upside
Upside
+462.1%
Quality
7
Marker Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 5
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, develops and commercializes T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications in the United States. The company's multi antigen recognizing (MAR)-T cell therapy technology is based on the selective expansion of non-engineered tumor-specific T cells that recognize tumor-associated antigens and kill tumor cells expressing those targets. It develops MT-601, which is in Phase 1 trials for the treatment of lymphoma and pancreatic cancer; and MT-401-OTS, which is in a Phase 1 trial for the treatment of acute myeloid leukemia and myelodysplastic syndromes. The company was formerly known as TapImmune, Inc. and changed its name to Marker Therapeutics, Inc. in October 2018. Marker Therapeutics, Inc. was founded in 1999 and is headquartered in Houston, Texas.
MRKR
Latest News
—
Caricamento notizie per MRKR…
stock quote shares MRKR – Marker Therapeutics Inc Stock Price stock today
news today MRKR – Marker Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MRKR – Marker Therapeutics Inc yahoo finance google finance
stock history MRKR – Marker Therapeutics Inc invest stock market
stock prices MRKR premarket after hours
ticker MRKR fair value insiders trading